77 related articles for article (PubMed ID: 28967097)
1. Mammalian target of rapamycin inhibition attenuates myocardial ischaemia-reperfusion injury in hypertrophic heart.
Ma LL; Ma X; Kong FJ; Guo JJ; Shi HT; Zhu JB; Zou YZ; Ge JB
J Cell Mol Med; 2018 Mar; 22(3):1708-1719. PubMed ID: 29314656
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin as longevity enhancer and cancer preventative agent in the context of p53 deficiency.
Donehower LA
Aging (Albany NY); 2012 Oct; 4(10):660-1. PubMed ID: 23128359
[TBL] [Abstract][Full Text] [Related]
3. Integrated Analysis of lncRNA-miRNA-mRNA Regulatory Network in Rapamycin-Induced Cardioprotection against Ischemia/Reperfusion Injury in Diabetic Rabbits.
Samidurai A; Olex AL; Ockaili R; Kraskauskas D; Roh SK; Kukreja RC; Das A
Cells; 2023 Dec; 12(24):. PubMed ID: 38132140
[TBL] [Abstract][Full Text] [Related]
4. mTORC1 and SGLT2 Inhibitors-A Therapeutic Perspective for Diabetic Cardiomyopathy.
Saha S; Fang X; Green CD; Das A
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894760
[TBL] [Abstract][Full Text] [Related]
5. Single-Dose Treatment with Rapamycin Preserves Post-Ischemic Cardiac Function through Attenuation of Fibrosis and Inflammation in Diabetic Rabbit.
Samidurai A; Saravanan M; Ockaili R; Kraskauskas D; Lau SYV; Kodali V; Ramasamy S; Bhoopathi K; Nair M; Roh SK; Kukreja RC; Das A
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240345
[TBL] [Abstract][Full Text] [Related]
6. Preclinical model of type 1 diabetes and myocardial ischemia/reperfusion injury in conscious rabbits-demonstration of cardioprotection with rapamycin.
Samidurai A; Ockaili R; Cain C; Roh SK; Filippone SM; Kraskauskas D; Kukreja RC; Das A
STAR Protoc; 2021 Sep; 2(3):100772. PubMed ID: 34485939
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle delivery of cardioprotective therapies.
Mendez-Fernandez A; Cabrera-Fuentes HA; Velmurugan B; Irei J; Boisvert WA; Lu S; Hausenloy DJ
Cond Med; 2020 Feb; 3(1):18-30. PubMed ID: 34268485
[TBL] [Abstract][Full Text] [Related]
8. Differential Regulation of mTOR Complexes with miR-302a Attenuates Myocardial Reperfusion Injury in Diabetes.
Samidurai A; Ockaili R; Cain C; Roh SK; Filippone SM; Kraskauskas D; Kukreja RC; Das A
iScience; 2020 Dec; 23(12):101863. PubMed ID: 33319180
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle-Mediated Drug Delivery for Treatment of Ischemic Heart Disease.
Fan C; Joshi J; Li F; Xu B; Khan M; Yang J; Zhu W
Front Bioeng Biotechnol; 2020; 8():687. PubMed ID: 32671049
[TBL] [Abstract][Full Text] [Related]
10. Is Rapamycin a Dietary Restriction Mimetic?
Unnikrishnan A; Kurup K; Salmon AB; Richardson A
J Gerontol A Biol Sci Med Sci; 2020 Jan; 75(1):4-13. PubMed ID: 30854544
[TBL] [Abstract][Full Text] [Related]
11. Effects of Cardiovascular Risk Factors on Cardiac STAT3.
Pipicz M; Demján V; Sárközy M; Csont T
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30424579
[TBL] [Abstract][Full Text] [Related]
12. Emerging Role of mTOR Signaling-Related miRNAs in Cardiovascular Diseases.
Samidurai A; Kukreja RC; Das A
Oxid Med Cell Longev; 2018; 2018():6141902. PubMed ID: 30305865
[TBL] [Abstract][Full Text] [Related]
13. Chronic treatment with novel nanoformulated micelles of rapamycin, Rapatar, protects diabetic heart against ischaemia/reperfusion injury.
Samidurai A; Salloum FN; Durrant D; Chernova OB; Kukreja RC; Das A
Br J Pharmacol; 2017 Dec; 174(24):4771-4784. PubMed ID: 28967097
[TBL] [Abstract][Full Text] [Related]
14. STAT3-miR-17/20 signalling axis plays a critical role in attenuating myocardial infarction following rapamycin treatment in diabetic mice.
Samidurai A; Roh SK; Prakash M; Durrant D; Salloum FN; Kukreja RC; Das A
Cardiovasc Res; 2020 Nov; 116(13):2103-2115. PubMed ID: 31738412
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of mammalian target of rapamycin protects against reperfusion injury in diabetic heart through STAT3 signaling.
Das A; Salloum FN; Filippone SM; Durrant DE; Rokosh G; Bolli R; Kukreja RC
Basic Res Cardiol; 2015 May; 110(3):31. PubMed ID: 25911189
[TBL] [Abstract][Full Text] [Related]
16. Lin28a protects against cardiac ischaemia/reperfusion injury in diabetic mice through the insulin-PI3K-mTOR pathway.
Zhang M; Sun D; Li S; Pan X; Zhang X; Zhu D; Li C; Zhang R; Gao E; Wang H
J Cell Mol Med; 2015 Jun; 19(6):1174-82. PubMed ID: 25688987
[TBL] [Abstract][Full Text] [Related]
17. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
[TBL] [Abstract][Full Text] [Related]
18. Reperfusion Therapy with Rapamycin Attenuates Myocardial Infarction through Activation of AKT and ERK.
Filippone SM; Samidurai A; Roh SK; Cain CK; He J; Salloum FN; Kukreja RC; Das A
Oxid Med Cell Longev; 2017; 2017():4619720. PubMed ID: 28373901
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
